Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ferrannini

Showing results (251-260 of 334) with videos related to

Pageof 34
Sort By:
The American Journal of Physiology|February 12, 1998
Effects of acute alpha 2-blockade on insulin action and secretion in humansA Natali, A Gastaldelli, A Q Galvan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled studyF Monzani, N Caraccio, M Kozàkowà, et al.
The Journal of Clinical Investigation|June 1, 1984
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabeticsD C Simonson, V Koivisto, R S Sherwin, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyD R Matthews, S Dejager, B Ahren, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Autonomic and hemodynamic responses to insulin in lean and obese humansE Muscelli, M Emdin, A Natali, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2005
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and durationN Caraccio, A Dardano, F Manfredonia, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibersS Pierno, A De Luca, D Tricarico, et al.
International Journal of Obesity (2005)|July 29, 2009
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight lossM Nannipieri, F Cecchetti, M Anselmino, et al.
Diabetologia|November 21, 2007
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinedionesD M Nathan, J B Buse, M B Davidson, et al.
Circulation|November 1, 2000
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humansA Q Galvan, F Galetta, A Natali, et al.
Pageof 34

Showing results (251-260 of 334) with videos related to

Sort By:
Pageof 34
The American Journal of Physiology|February 12, 1998
Effects of acute alpha 2-blockade on insulin action and secretion in humansA Natali, A Gastaldelli, A Q Galvan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled studyF Monzani, N Caraccio, M Kozàkowà, et al.
The Journal of Clinical Investigation|June 1, 1984
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabeticsD C Simonson, V Koivisto, R S Sherwin, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyD R Matthews, S Dejager, B Ahren, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Autonomic and hemodynamic responses to insulin in lean and obese humansE Muscelli, M Emdin, A Natali, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2005
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and durationN Caraccio, A Dardano, F Manfredonia, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibersS Pierno, A De Luca, D Tricarico, et al.
International Journal of Obesity (2005)|July 29, 2009
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight lossM Nannipieri, F Cecchetti, M Anselmino, et al.
Diabetologia|November 21, 2007
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinedionesD M Nathan, J B Buse, M B Davidson, et al.
Circulation|November 1, 2000
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humansA Q Galvan, F Galetta, A Natali, et al.
Pageof 34